50 related articles for article (PubMed ID: 8513506)
1. Increased IgE level as a marker of host-versus-graft disease: inhibition of this HVGD with a monoclonal antibody to IL-4.
Takai S; Tateno M; Hirano T; Kondo N; Hirose S; Yoshiki T
Cell Immunol; 1993 Jun; 149(1):1-10. PubMed ID: 8513506
[TBL] [Abstract][Full Text] [Related]
2. Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease.
Ushiyama C; Hirano T; Miyajima H; Okumura K; Ovary Z; Hashimoto H
J Immunol; 1995 Mar; 154(6):2687-96. PubMed ID: 7876541
[TBL] [Abstract][Full Text] [Related]
3. In vivo effects of anti-IL-4 monoclonal antibody on neonatal induction of tolerance and on an associated autoimmune syndrome.
Schurmans S; Heusser CH; Qin HY; Merino J; Brighouse G; Lambert PH
J Immunol; 1990 Oct; 145(8):2465-73. PubMed ID: 2212649
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune syndrome after induction of neonatal tolerance to I-E antigens.
Gonzalez AL; Conde C; Revilla C; Ramos A; Renedo B; Merino J
Eur J Immunol; 1993 Sep; 23(9):2353-7. PubMed ID: 8370412
[TBL] [Abstract][Full Text] [Related]
5. IL-4 is required for the IgE and IgG1 increase and IgG1 autoantibody formation in mice treated with mercuric chloride.
Ochel M; Vohr HW; Pfeiffer C; Gleichmann E
J Immunol; 1991 May; 146(9):3006-11. PubMed ID: 2016536
[TBL] [Abstract][Full Text] [Related]
6. Tumor induction in host-versus-graft disease. I. Clinical and pathologic features.
Cornelius EA
Am J Pathol; 1978 Mar; 90(3):675-88. PubMed ID: 24343
[TBL] [Abstract][Full Text] [Related]
7. Engineered recombinant ovomucoid third domain can modulate allergenic response in Balb/c mice model.
Rupa P; Mine Y
Biochem Biophys Res Commun; 2006 Apr; 342(3):710-7. PubMed ID: 16494843
[TBL] [Abstract][Full Text] [Related]
8. Host-versus-graft disease in mice after the induction of neonatal transplantation tolerance by two different methods.
Pipis J; Jánossy T; Modok S; Ocsovszki I; Hidvégi Z; Horváth G; Végh P; Benner R
Acta Chir Hung; 1997; 36(1-4):280-1. PubMed ID: 9408374
[TBL] [Abstract][Full Text] [Related]
9. Anti-IL-4 monoclonal antibody prevents antibiotics-induced active fatal anaphylaxis.
Park JS; Choi IH; Lee DG; Han SS; Ha TY; Lee JH; Lee WH; Park YM; Lee HK
J Immunol; 1997 May; 158(10):5002-6. PubMed ID: 9144520
[TBL] [Abstract][Full Text] [Related]
10. Anti-T cell receptor antibody treatment of mice with lupus-like graft versus host disease: suppression of glomerulonephritis without reduction in anti-DNA antibody levels.
Maeda T; Nomoto K
J Rheumatol; 1995 Dec; 22(12):2259-65. PubMed ID: 8835559
[TBL] [Abstract][Full Text] [Related]
11. The extract of syngeneic keratinocytes enhances IgE production from BALB/c mouse splenic lymphocytes in vitro.
Morimoto K; Nabeshima Y; Mochizuki M; Oomizu S; Yamamoto S; Hide M
Arch Dermatol Res; 2006 Feb; 297(8):358-66. PubMed ID: 16402182
[TBL] [Abstract][Full Text] [Related]
12. An antagonistic IL-4 mutant prevents type I allergy in the mouse: inhibition of the IL-4/IL-13 receptor system completely abrogates humoral immune response to allergen and development of allergic symptoms in vivo.
Grunewald SM; Werthmann A; Schnarr B; Klein CE; Bröcker EB; Mohrs M; Brombacher F; Sebald W; Duschl A
J Immunol; 1998 Apr; 160(8):4004-9. PubMed ID: 9558109
[TBL] [Abstract][Full Text] [Related]
13. Anti-IL-4 antibody inhibits antigen specific IgE response but fails to prevent chicken gamma globulin-induced active systemic anaphylaxis: evidence for the involvement of IgG antibodies.
Lee HK; Lee HH; Park YM; Park HJ; Lee JH; Ha TY
J Korean Med Sci; 1996 Apr; 11(2):111-7. PubMed ID: 8835757
[TBL] [Abstract][Full Text] [Related]
14. IL-4-dependent induction of IgE basophils in peripheral blood and IgE B cells in spleen as respective indicators of allergen sensitization and a precursor of cells secreting allergen-specific IgE antibody.
Miyoshi-Higashino M; Hirano M; Ogita-Nakanishi H; Yamamoto-Kimoto Y; Sakurai K; Tashiro-Yamaji J; Nomi H; Takahashi T; Miura-Takeda S; Takenaka H; Kubota T; Yoshida R
Microbiol Immunol; 2009 Jan; 53(1):30-40. PubMed ID: 19161555
[TBL] [Abstract][Full Text] [Related]
15. Characterization of reactivity of monoclonal autoantibodies with renal antigens in experimental lupus nephritis.
Kootstra JC; Veninga A; Baelde JJ; van Eendenburg J; de Heer E; Bruijn JA
J Clin Lab Immunol; 1996; 48(5):201-18. PubMed ID: 9394243
[TBL] [Abstract][Full Text] [Related]
16. The expression of murine cutaneous late phase reaction requires both IgE antibodies and CD4 T cells.
Sawada K; Nagai H; Basaki Y; Yamaya H; Ikizawa K; Watanabe M; Kojima M; Matsuura N; Kiniwa M
Clin Exp Allergy; 1997 Feb; 27(2):225-31. PubMed ID: 9061224
[TBL] [Abstract][Full Text] [Related]
17. Increase in serum IgE levels following injection of syngeneic keratinocyte extracts in BALB/c mice.
Yamamoto T; Kaneko S; Hide M; Mochizuki M; Morimoto K; Yoshimura M; Yamamoto S
Arch Dermatol Res; 2002 May; 294(3):117-23. PubMed ID: 12029497
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies in human chronic graft-versus-host disease after hematopoietic cell transplantation.
Quaranta S; Shulman H; Ahmed A; Shoenfeld Y; Peter J; McDonald GB; Van de Water J; Coppel R; Ostlund C; Worman HJ; Rizzetto M; Tsuneyama K; Nakanuma Y; Ansari A; Locatelli F; Paganin S; Rosina F; Manns M; Gershwin ME
Clin Immunol; 1999 Apr; 91(1):106-16. PubMed ID: 10219261
[TBL] [Abstract][Full Text] [Related]
19. Tolerance induction by anti-CD2 plus anti-CD3 monoclonal antibodies: evidence for an IL-4 requirement.
Punch JD; Tono T; Qin L; Bishop DK; Bromberg JS
J Immunol; 1998 Aug; 161(3):1156-62. PubMed ID: 9686574
[TBL] [Abstract][Full Text] [Related]
20. Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice.
Nagler A; Pines M; Abadi U; Pappo O; Zeira M; Rabbani E; Engelhardt D; Ohana M; Chowdhury NR; Chowdhury JR; Ilan Y
Hepatology; 2000 Mar; 31(3):641-8. PubMed ID: 10706554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
